Literature DB >> 7756842

Overexpression and characterization of human tetrameric pyruvate dehydrogenase and its individual subunits.

L G Korotchkina1, M M Tucker, T J Thekkumkara, K T Madhusudhan, G Pons, H Kim, M S Patel.   

Abstract

Pyruvate dehydrogenase (E1), an alpha 2 beta 2 tetramer, is the first component of the pyruvate dehydrogenase complex which catalyzes a two-step oxidative decarboxylation of pyruvic acid. To overexpress human E1 and its subunits individually, cDNAs for the mature forms of human E1 alpha and E1 beta were subcloned either individually or together into a plasmid pQE-9 and expressed in Escherichia coli M15. A polyhistidine extension was added at the NH2-termini of the recombinant E1 alpha and E1 beta for the rapid purification of the proteins by Ni-nitrilotriacetic-agarose chromatography. The polyhistidine extension on either E1 alpha or E1 beta subunit did not affect the activity of the recombinant tetrameric E1. Highly purified recombinant human E1 catalyzed the partial reactions of the oxidative and nonoxidative conversion of pyruvic acid with the same efficiency as E1 purified from bovine kidney. Recombinant human E1 interacted with thiamin pyrophosphate by forming a charge transfer complex band at 330 nm that changed during the catalytic cycle. Recombinant human E1 was phosphorylated by E1-kinase (with concomitant inactivation) by incorporating nearly three phosphoryl groups per mole of E1. When expressed individually, E1 alpha and E1 beta subunits lacked any catalytic activity in the oxidative or nonoxidative reactions. Spectral studies demonstrated that there was no thiamin pyrophosphate binding to either recombinant E1 alpha or E1 beta subunit. The E1 alpha subunit retained the ability to be phosphorylated; however, the incorporation of phosphoryl groups into recombinant E1 alpha alone was only about 12% of that observed with the tetrameric E1. These findings show that both subunits are required for formation of the active center and catalysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756842     DOI: 10.1006/prep.1995.1011

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Effects of antisense repression of an Arabidopsis thaliana pyruvate dehydrogenase kinase cDNA on plant development.

Authors:  J Zou; Q Qi; V Katavic; E F Marillia; D C Taylor
Journal:  Plant Mol Biol       Date:  1999-12       Impact factor: 4.076

2.  Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the αV138M variant of human pyruvate dehydrogenase.

Authors:  Matthew J Whitley; Palaniappa Arjunan; Natalia S Nemeria; Lioubov G Korotchkina; Yun-Hee Park; Mulchand S Patel; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2018-07-03       Impact factor: 5.157

3.  The effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a proteomic analysis.

Authors:  X Shi; X G Lu; L B Zhan; X Qi; L N Liang; S Y Hu; Y Yan; S Y Zhao; H Sui; F L Zhang
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

4.  Biochemical characterization of two mutants of human pyruvate dehydrogenase, F205L and T231A of the E1alpha subunit.

Authors:  Yong-Ge Wu; Wen-Yang Chen; Zi-Wei Zhang; Gui-Zheng Yang; Wei Li; Ronald G Duggleby
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  Formation of reactive oxygen species by human and bacterial pyruvate and 2-oxoglutarate dehydrogenase multienzyme complexes reconstituted from recombinant components.

Authors:  Attila Ambrus; Natalia S Nemeria; Beata Torocsik; Laszlo Tretter; Mattias Nilsson; Frank Jordan; Vera Adam-Vizi
Journal:  Free Radic Biol Med       Date:  2015-10-09       Impact factor: 7.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.